[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Doximity Inc Cl A (DOCS)

Doximity Inc Cl A (DOCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,664,755
  • Shares Outstanding, K 182,872
  • Annual Sales, $ 644,860 K
  • Annual Income, $ 196,050 K
  • EBIT $ 215 M
  • EBITDA $ 235 M
  • 60-Month Beta 1.30
  • Price/Sales 5.68
  • Price/Cash Flow 16.15
  • Price/Book 3.85

Options Overview Details

View History
  • Implied Volatility 51.45% (-1.46%)
  • Historical Volatility 92.04%
  • IV Percentile 32%
  • IV Rank 26.41%
  • IV High 108.94% on 05/13/26
  • IV Low 30.81% on 09/17/25
  • Expected Move (DTE 2) 1.00 (4.85%)
  • Put/Call Vol Ratio 2.87
  • Today's Volume 746
  • Volume Avg (30-Day) 1,941
  • Put/Call OI Ratio 0.75
  • Today's Open Interest 52,220
  • Open Int (30-Day) 46,069
  • Expected Range 19.68 to 21.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.16
  • Number of Estimates 5
  • High Estimate $0.20
  • Low Estimate $0.13
  • Prior Year $0.27
  • Growth Rate Est. (year over year) -40.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.36 +12.64%
on 05/20/26
22.65 -8.70%
on 06/01/26
+1.71 (+9.01%)
since 05/15/26
3-Month
17.15 +20.58%
on 05/14/26
26.69 -22.52%
on 05/12/26
-3.69 (-15.14%)
since 03/13/26
52-Week
17.15 +20.58%
on 05/14/26
76.51 -72.97%
on 09/29/25
-35.24 (-63.02%)
since 06/13/25

Most Recent Stories

More News
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES , June 11, 2026 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Doximity,...

DOCS : 20.68 (+3.19%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

NEW YORK , June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS).  Such investors are advised to...

DOCS : 20.68 (+3.19%)
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES , June 8, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Doximity, Inc....

DOCS : 20.68 (+3.19%)
Did Five Below, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

DOCS : 20.68 (+3.19%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

NEW YORK , June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS).  Such investors are advised to...

DOCS : 20.68 (+3.19%)
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or “the Company”) (NYSE:...

DOCS : 20.68 (+3.19%)
1 Profitable Stock to Keep an Eye On and 2 Facing Challenges

1 Profitable Stock to Keep an Eye On and 2 Facing Challenges

ADT : 6.70 (-1.47%)
DOCS : 20.68 (+3.19%)
DPZ : 316.52 (-2.27%)
Workday and Doximity Shares Are Soaring, What You Need To Know

Workday and Doximity Shares Are Soaring, What You Need To Know

DOCS : 20.68 (+3.19%)
WDAY : 129.60 (-0.92%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

NEW YORK , May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS).  Such investors are advised to...

DOCS : 20.68 (+3.19%)
1 Cash-Producing Stock to Keep an Eye On and 2 We Brush Off

1 Cash-Producing Stock to Keep an Eye On and 2 We Brush Off

PHM : 122.84 (-0.27%)
DOCS : 20.68 (+3.19%)
BRBR : 8.86 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date...

See More

Key Turning Points

3rd Resistance Point 21.54
2nd Resistance Point 21.13
1st Resistance Point 20.91
Last Price 20.68
1st Support Level 20.28
2nd Support Level 19.87
3rd Support Level 19.65

See More

52-Week High 76.51
Fibonacci 61.8% 53.83
Fibonacci 50% 46.83
Fibonacci 38.2% 39.83
Last Price 20.68
52-Week Low 17.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.